Antigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host (Q36567799)

15 August 2017

1 reference

title

Antigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host (English)

1 reference

15 August 2017

1 reference

1 reference

1

Wheat LJ

1 reference

15 August 2017

1 September 2006

1 reference

Transplant Infectious Disease

15 August 2017

1 reference

15 August 2017

8

1 reference

15 August 2017

3

1 reference

15 August 2017

128-139

1 reference

Rapid diagnosis of invasive aspergillosis by antigen detection

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Prospective clinical evaluation of a LightCycler-mediated polymerase chain reaction assay, a nested-PCR assay and a galactomannan enzyme-linked immunosorbent assay for detection of invasive aspergillosis in neutropenic cancer patients and haematolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Detection of Aspergillus galactomannan antigenemia to determine biological and clinical implications of beta-lactam treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Discordant rise in galactomannan antigenemia in a patient with resolving Aspergillosis, renal failure, and ongoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Bifidobacterial lipoglycan as a new cause for false-positive platelia Aspergillus enzyme-linked immunosorbent assay reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Cryptococcus neoformans Galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus Galactomannan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Value of antigen detection using an enzyme immunoassay in the diagnosis and prediction of invasive aspergillosis in two adult and pediatric hematology units during a 4-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Utility of Aspergillus antigen detection in specimens other than serum specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Galactomannan detection in computerized tomography‐based broncho‐alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Efficacy of galactomannan antigen in the Platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Aspergillus antigenemia sandwich-enzyme immunoassay test as a serodiagnostic method for invasive aspergillosis in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Aspergillus antigen in serum, urine and bronchoalveolar lavage specimens of neutropenic patients in relation to clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still a ways to go.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Development of a serum-based Taqman real-time PCR assay for diagnosis of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Current diagnosis of histoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Antigen assay with the potential to aid in diagnosis of blastomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Differences in clinical and laboratory diagnostic characteristics of penicilliosis marneffei in human immunodeficiency virus (HIV)- and non-HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Development and evaluation of rapid urinary antigen detection tests for diagnosis of penicilliosis marneffei

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Antigen detection assay for identification of Penicillium marneffei infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Detection of Paracoccidioides brasiliensis gp70 circulating antigen and follow-up of patients undergoing antimycotic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Detection of circulating gp43 antigen in serum, cerebrospinal fluid, and bronchoalveolar lavage fluid of patients with paracoccidioidomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Detection of cryptococcal antigen in bronchoalveolar lavage fluid: a prospective study of diagnostic utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Cryptococcal antigen test revisited: significance for cryptococcal meningitis therapy monitoring in a tertiary chinese hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoplasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Diagnosis and management of central nervous system histoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

False-positive Histoplasma antigenemia caused by antithymocyte globulin antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Histoplasmosis in Indianapolis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Immunoglobulin M and G histoplasmal antibody response in histoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Evaluation of two nested PCR assays for detection of Histoplasma capsulatum DNA in human tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Serological tests for blastomycosis: assessments during a large point-source outbreak in Wisconsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Utility of anti-WI-1 serological testing in the diagnosis of blastomycosis in Wisconsin residents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

New serologic tests for early detection of coccidioidomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Coccidioidomycosis in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Detection of antibodies to Coccidioides immitis by enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Characterization of a serodiagnostic complement fixation antigen of Coccidioides posadasii expressed in the nonpathogenic Fungus Uncinocarpus reesii

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Coccidioidomycosis in persons infected with HIV type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Coccidioidomycosis in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Coccidioidomycosis in patients infected with human immunodeficiency virus: review of 91 cases at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Rapid diagnostic evaluation of bronchial washings in patients with suspected coccidioidomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Coccidioidomycosis among workers at an archeological site, northeastern Utah

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Serologic studies in coccidioidomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

21 January 2018

Coccidioidal meningitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Monitoring gp43 antigenemia in Paracoccidioidomycosis patients during therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Improvement of the specificity of an enzyme-linked immunosorbent assay for diagnosis of paracoccidioidomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00165.X

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

21 January 2018

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1086/422009

Identifiers

DOI

10.1111/J.1399-3062.2006.00165.X

1 reference

15 August 2017

1 reference

PubMed ID

16913971